1
GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC
Condition(s):Metastatic NSCLCLast Updated:August 8, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.